MedTrace Logo

Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

NCT00243490 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2010-01-12

No results posted yet for this study

Summary

Primary Objective:

* The primary objective is to evaluate the efficacy of photodynamic therapy in the treatment of malignant intracranial tumors.

Secondary Objective:

* The secondary objective is to evaluate the safety of photodynamic therapy in the treatment of malignant intracranial tumors.

Conditions

  • Malignant Intracranial Tumors
  • Glioblastoma Multiforme
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Anaplastic Ependymoma

Interventions

PROCEDURE

Photodynamic therapy using Photosan and LumaCare™ Lamp Model LC-122M

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Jui-Chang Tsai, M.D. Ph.D. · National Taiwan University College of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2009-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00243490 on ClinicalTrials.gov